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Abstract
Background: Coronary Heart Disease and Cerebrovascular Disease share many predisposing, modifiable
risk factors (hypertension, abnormal blood lipids and lipoproteins, cigarette smoking, physical inactivity,
obesity and diabetes mellitus). Lifestyle interventions and pharmacological therapy are recognised as the
cornerstones of secondary prevention. Cochrane review has proven the benefits of programmes
incorporating exercise and lifestyle counselling in the cardiac disease population. A Cochrane review
highlighted as priority, the need to establish feasibility and efficacy of exercise based interventions for
Cerebrovascular Disease.
Methods: A single blind randomised controlled trial is proposed to examine a primary care cardiac
rehabilitation programme for adults post transient ischemic attack (TIA) and stroke in effecting a positive
change in the primary outcome measures of cardiac risk scores derived from Blood Pressure, lipid profile,
smoking and diabetic status and lifestyle factors of habitual smoking, exercise and healthy eating
participation. Secondary outcomes of interest include health related quality of life as measured by the
Hospital Anxiety and Depression Scale, the Stroke Specific Quality of Life scale and WONCA COOP
Functional Health Status charts and cardiovascular fitness as measured by a sub-maximal fitness test.
A total of 144 patients, over 18 years of age with confirmed diagnosis of ischaemic stroke or TIA, will be
recruited from Dublin community stroke services and two tertiary T.I.A clinics. Exclusion criteria will
include oxygen dependence, unstable cardiac conditions, uncontrolled diabetes, major medical conditions,
claudication, febrile illness, pregnancy or cognitive impairment. Participants will be block-statified,
randomly allocated to one of two groups using a pre-prepared computer generated randomisation
schedule. Both groups will receive a two hour education class on risk reduction post stroke. The
intervention group will receive a 10 week programme of supervised aerobic exercises (twice weekly) and
individually tailored brief intervention lifestyle counselling. Both groups will be tested on week one and
week ten of the programme. Follow-up at 1 year will assess longer term benefits. Analysis will test for
significant changes in the key variables indicated.
Discussion: Application of the Cardiac Rehabilitation paradigm to patients with ischaemic stroke or TIA
has not been explored despite the obvious overlap in aetiology. It is hoped the anticipated improvement
in vascular risk factors and fitness resulting from such a programme will enhance health and social gain in
this population.
Trial Registration: Current Controlled Trials ISCTRN90272638.
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Background
Stroke is the third leading cause of death and disability
worldwide. It constitutes a formidable burden of disabil-
ity for patients, their families, health professionals and the
wider community. It combines aspects of both acute and
chronic disease, and there is increasing evidence that
those affected by stroke can benefit to a very significant
extent from organised stroke care throughout the course
of the illness. Delivering this care requires a combination
of skills that draw on neurosciences, cardiovascular medi-
cine, general medicine, the science of ageing, rehabilita-
tion, vascular surgery, and public health[1].
Both coronary heart disease (CHD) and ischaemic stroke
share links to many of the same predisposing, potentially
modifiable risk factors (hypertension, abnormal blood
lipids and lipoproteins, cigarette smoking, physical inac-
tivity, obesity and diabetes mellitus). This highlights the
prominent role lifestyle plays in the origin of cardiovascu-
lar disease [2]. Modification of multiple risk factors
through a combination of lifestyle interventions and
appropriate pharmacological therapy is now recognised
as the cornerstone of initiatives aimed at prevention of
recurrent stroke and acute cardiac events in stroke survi-
vors [3-5].
Falling CHD and stroke mortality rates means a higher
prevalence of those at risk of further events thus increasing
the need for disease management, secondary prevention
and cardiac rehabilitation [6]. Patients with a recent
ischaemic stroke or transient ischemic attack (TIA) are at
high risk for further vascular events and vascular death
[7,8]. At least 15% of stroke survivors will have a second
stroke during the next five years, quarter of which prove
fatal within four weeks [9]. Prospective studies following
TIA found incidence of stroke to be 11% within 90 days.
Longer term studies found that while the risk of major vas-
cular events- stroke, myocardial infarct (MI) and vascular
death is mainly concentrated in the weeks following TIA,
it remains elevated for many years afterwards [10,11].
Current evidence for secondary prevention is dominated
by pharmacological interventions, while the evidence
available for life-style modifications such as dietary
change and physical exercise is less robust. Modification
of major cardiovascular risk factors (blood cholesterol,
high blood pressure and smoking) is reported to be cost-
effective but needs to be better targeted if potential health
gain is to be realised [12].
Given the proven benefits of regular physical activity on
cardiovascular disease risk factors in able-bodied individ-
uals [13,14] and in the post MI and coronary grafting
(CABG) populations [15,16], the support for cardiovascu-
lar training in stroke survivors is growing. The need for
research into the effects of such programmes has recently
been highlighted as a priority by the American Stroke
Association (ASA) [2] and Cochrane Review [17].
While it is reported that cardiac disease occurs in up to
75% of stroke survivors, exertion at the levels used in
rehabilitation programmes after stroke is associated with
low risk of serious cardiovascular complications [2]. The
proposed research, which also aims to exercise this popu-
lation at light to moderate i.e. submaximal intensities of ≤
60% of their maximal heart rate, poses very low risk to the
participants of adverse events and is within the recom-
mended guidelines of the ASA at 50–80%. This is further
supported by a study reporting a low frequency of medical
complications during inpatient rehabilitation post stroke
(No myocardial infarctions) [18]. In a scientific statement
on physical activity after stroke the American Heart Asso-
ciation (AHA) espouse the use of aerobic conditioning
post stroke to improve cardiovascular risk factors and rec-
ommend its use for stroke survivors as part of a compre-
hensive stroke and cardiovascular risk reduction
programme [2].
The concept of cardiovascular fitness for stroke survivors
has been addressed in a number of studies to date. The
Cochrane review on Physical Fitness Training in Stroke
Patients [17] includes 11 clinical trials. Of these however
only two [19,20] included measures of aerobic fitness
(VO2) and maximal work rate (Watts) as defined out-
come variables. Similarly only 2 studies [19,21] described
the intensity and progression of fitness training as a per-
centage of the participants maximal capacity, thus meet-
ing the American College of Sports Medicine (ACSM)
guidelines for developing cardiorespiratory fitness [22].
The randomised controlled trial by Potempa et al. [19]
found that stroke patients could increase their cardiovas-
cular fitness by a magnitude similar to that of healthy
older adults who engage in endurance training. However,
as only 7% of patients discharged from rehabilitation post
stroke meet the criteria for community walking (e.g. a
speed that would allow them to cross a road safely), few
stroke patients are able to avail of cardiovascular training
through the traditional method of treadmill training used
in this study.
A cycle ergometer with adaptive devices as necessary can
allow aerobic fitness training in this population of more
dependent stroke survivors. Treadmill, bicycle, upper
limb ergometry and step training can be used in the TIA
and less disabled stroke subjects. Traditionally cycle
ergometry studies have looked at exercise capacity and self
concept in stroke patients following exercise training only.
A study addressing exercise in men with Coronary Artery
Disease (CAD) and physical disability [23] demonstrated
significant increases in peak left ventricular ejection frac-BMC Neurology 2009, 9:9 http://www.biomedcentral.com/1471-2377/9/9
Page 3 of 8
(page number not for citation purposes)
tion and high-density lipoprotein cholesterol and
decreases in resting heart rate following training.
More recent studies in the stroke population have demon-
strated water based exercise [24], treadmill training [25]
and a community-based exercise and mobility pro-
gramme [26] can increase cardiovascular fitness after
stroke, but a search of the literature has found no studies
exploring the effects of an intensive programme consist-
ing of progressive cardiorespiratory training which con-
forms to ACSM guidelines, accompanied by lifestyle
counselling and targeted smoking cessation. These inter-
ventions are common components of 'Comprehensive
Cardiac Rehabilitation Programmes' but this paradigm
has not been applied to the Stroke and TIA population
Background work
A pilot study was conducted in 2005 looking at the feasi-
bility of a 10 week cardiovascular training programme in
the non-acute ischaemic stroke population [27]. This
work highlighted the efficacy of the programme in reduc-
ing cardiac risk scores and improving cardiovascular fit-
ness in the stroke population. It also demonstrated the
safety of the programme with no adverse events occurring
during the exercise regime.
Focus groups were subsequently conducted with 4 groups
of community dwelling stroke patients (5–6 participants
per group) to establish perceived barriers to healthy life-
style participation, preferred options for receiving infor-
mation and advice and to gain end-user input into the
final programme development for this clinical trial. Con-
versations were transcribed verbatim and subjected to the-
matic coding and analysis as guided by Miles and
Huberman [28].
Reason for expansion of the study
Given the proven safety record and notable benefits, it was
decided to expand the study to include the post TIA pop-
ulation. As this population have no acquired physical dis-
ability, secondary prevention will have greater cost benefit
to the health service by reducing the shared risk factors for
the occurrence of stroke (currently estimated at 15%
within 5 years) and development of other cardiovascular
disease (CVD).
Cochrane Reviews of dietary advice, smoking cessation
and stress management counselling as part of a compre-
hensive cardiac rehabilitation programme (CCR) in the
CVD population concluded that:
￿ Dietary advice appears to be effective in bringing about
modest beneficial changes in diet and cardiovascular risk
factors over approximately 9 months but longer term
effects are not known [29].
￿ Behavioural counselling for smoking cessation indi-
cated that individual counselling was more effective than
control. The odds ratio for successful smoking cessation
was 1.56 (95% confidence interval 1.32 to 1.84). A greater
effect was not detected by intensive counselling compared
to brief counselling (odds ratio 0.98, 95% confidence
interval 0.61 to 1.56) [30].
￿ Quitting smoking is associated with a substantial reduc-
tion in risk of all-cause mortality among patients with
CHD. The pooled crude RR was 0.64 (95% CI 0.58 to
0.71). This 36% risk reduction appears substantial com-
pared with other secondary preventive therapies such as
cholesterol lowering which have received greater attention
in recent years [31].
￿ Overall psychological interventions showed no evidence
of effect on total or cardiac mortality, but did show small
reductions in anxiety and depression in patients with
CHD. Similar results were seen for stress management
interventions when considered separately [32].
Although brief clinician interventions addressing physical
activity and diet have been less studied than smoking ces-
sation programmes, evidence exists that these types of
interventions can influence patients to consider and adopt
changes in how they eat and their physical activity levels
[33,34]. Success of programmes to increase walking and
other types of physical activity [34], change dietary behav-
iour, such as encouraging people to eat more fruit and
vegetables in the 5-a-day program [36] further support cli-
nicians' efforts to intervene in these areas.
Based on the evidence of effect of these interventions as
part of CCR, adoption of the paradigm to the Stroke and
TIA population appears to be warranted.
The aims of the proposed study are to determine whether
a 10 week comprehensive cardiac rehabilitation pro-
gramme for adults post TIA and ischaemic stroke includ-
ing aerobic training, dietary and exercise advice, life skills
and smoking cessation counselling:
(i) Reduces overall cardiac risk score, calculated from
Blood Pressure, lipid profile, age, sex and diabetic status
[38].
(ii) Increases participants' adherence to the Fourth Joint
European Societies' Task Force on Cardiovascular Disease
Prevention in Clinical Practice for a high risk group [39]
eg by effecting a change in smoking habit as demonstrated
by % reduction in smoking, healthy heart diet compliance
by daily fruit(2) and veg (3)intake, habitual exercise
habit, i.e. % taking moderate and/or vigorous exercise 3BMC Neurology 2009, 9:9 http://www.biomedcentral.com/1471-2377/9/9
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times per week extrapolated from the International Phys-
ical Activity Questionnaire (IPAQ) [40].
Secondary outcomes of interest associated with the pro-
gramme include: (i) Cardiovascular fitness as calculated
by a submaximal cycle ergometry test of VO2 max and
peak rate pressure product (PRPP). (ii) Health Related
Quality of Life as measured by the Hospital Anxiety and
Depression Scale scores [41], Stroke Specific Quality of
Life Index [42] and Functional Health Status Charts
COOP/WONCA [43].
Methods
The Cochrane criteria for assessing methodological qual-
ity of clinical trials and the Consort checklist for publica-
tion were consulted to ensure methodological rigor in the
design of this study.
Randomisation procedure
Since blinding to the cardiac rehabilitation programme
intervention is not possible, a randomised, controlled,
single-blind trial is proposed. Patients recruited for this
trial will be randomly assigned to a cardiac rehabilitation
group and a non-cardiac rehabilitation group. Partici-
pants will be stratified into Stroke and TIA groups and
block randomisation using blocks of 12 will be performed
using a computer generated randomisation schedule
(SPSS v12.0) prepared by an independent party in
advance. Concealed allocation will be ensured through
the use of opaque sealed envelopes.
Observer blinding
All measurements (baseline, post intervention and 1 year
review) will be made by an independent assessor (CB)
blind to the treatment allocation.
Intervention
The cardiac rehabilitation group will participate in a 10
week programme including 8 weeks physiotherapy led
(OL), individually tailored aerobic exercise for one hour
twice weekly at up to 60% of their maximal heart rate.
They will receive a two hour didactic lecture addressing
modifiable risk factors for stroke and stress management
(OL and AC). In addition individual brief smoking cessa-
tion counselling, exercise and dietary advice (OL) includ-
ing information leaflets in accordance with the WHO
guidelines for secondary prevention in low and medium
resource settings [44] will be provided to those failing to
meet the recommended guidelines.
To minimise the Hawthorne effect, the control group will
attend the two hour risk reduction lecture as outlined
above.
Participant Recruitment
Subjects with ischaemic stroke will be recruited from the
outpatient Stroke Rehabilitation Unit, Baggot Street Com-
munity Hospital, from the 4 community based stroke sup-
port groups. TIA subjects will be recruited from a TIA
clinic in a tertiary hospital in the greater Dublin. Informa-
tion leaflets will be distributed to potential subjects fulfill-
ing the inclusion criteria in the Stroke Rehabilitation Unit
database, Baggot Street Community Hospital and TIA
clinic in AMNCH Hospital, with the consent of the Con-
sultant Neurologist in this centre. Interested subjects will
then contact the principle researcher (OL) should they
wish to participate. Talks will be given at each support
group branch meeting and information leaflets distrib-
uted. Participants will then be screened by phone to
ensure they fulfil the inclusion criteria and that none of
the exclusion criteria apply. The American College of
Sports Medicine PARQ [22] questionnaire will be incor-
porated in the screening process to exclude subjects
unsuitable for exercise testing. The General Practitioners
of those attending the support groups will be contacted to
give permission for patients to attend the programme and
to consent to access medical records where necessary. A
one week period between the information dissemination
and consent will be given to allow due time for partici-
pants to consider the study.
Inclusion Criteria
Medically stable post ichaemic stroke or (> 3 months)
post TIA, referred from specialist tertiary centres. > 1 year
post ischaemic stroke with G.P. consent from community
services. Over 18 years of age of either sex.
Exclusion Criteria
O2 dependence, angina, unstable cardiac conditions,
unstable diabetes, major medical conditions, claudica-
tion, febrile illness, pregnancy or cognitive impairment.
Sample size calculations based on the ability to detect
significant differences in the key outcome variables with
80% power and p < 0.05 are indicated in table 1. Cardiac
risk data was taken from the pilot study and adherence to
European guidelines for lifestyle participation in a high
risk CVD group was taken from baseline data of the first
50 subjects recruited to the CRAFTS trial. The formulae for
detecting change in % was n > = K [P1(1 - P1) + P2 (1-P2)]/
Δ2. The formula for detecting a change in means was n >=
2Kσ2/Δ2K = 7.8. Our pilot study [27] resulted in a with-
drawal rate of 5% overall. Based on primary outcome
measures of adherence to all three European lifestyle
guidelines and cardiac risk score reduction with an antici-
pated drop-out rate of 10%, 144 participants will be
recruited. 72 randomised to the intervention group and
72 to the control group.BMC Neurology 2009, 9:9 http://www.biomedcentral.com/1471-2377/9/9
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Consent
Subjects will sign an informed consent statement
approved by AMNCH and University College Dublin Eth-
ics Committees prior to participation. Consent will also
be sought to access medical records in the hospital of
admission and also to contact their General Practitioners
(GP). The GP's of all consenting participants will be
informed of their agreement to participate and will be
asked to inform the study team should they know of any
contra-indications to exercise. A further medical screening
will be provided prior to sub-maximal exercise testing.
Table 1: Sample size calculations
% adherence to European 
Guidelines on CVD 
prevention in high risk 
group
(CRAFTS baseline data)
Target change to 
detect %
Sample size per group
Moderate or vigorous 
exercise for 20 mins 3 or 
more times/week
17 Increase by 20% 73
Dietary intake of 3 
vegetables portions & 2 
fruit portions or more/day
21 Increase by 20% 80
No smoking % in stroke 
and TIA patient population
85 Increase by 15% 61
% subjects fulfilling all 3 
criterion
9 Increase by 20% 56
Mean (sd) of baseline 
measures from pilot 
study in stroke patients
Mean change in 
intervention group – 
pilot study
Target change to 
detect
Cardiac Risk Score 9.4 (6.80) 1.52 4.0 72
VO2 exercise test 10.87 (1.71) 1.48 1.0 46
HAD – Anxiety subscale 6.13 (3.71) 0.86 1.5 54
Table 2: Variables and measurement instruments













Waist girth Tape measure √√ √
Lipid profile 
(Cholesterol, trigylceride, HDL, LDL)
Biochemical analysis √√ √
Blood Pressure Sphygomanometer √√ √
Mortality √
Non-fatal CVD/CeVD Event √
Physical Fitness & Function
Resting HR Polar heart rate monitor √√
Height, Weight, BMI Weighing Scales & Meter Rule √√ √
Aerobic Fitness – VO2 Astrand Rhyming submaximal exercise test with 
cycle ergometer
√√ √
Peak Rate Pressure Product Polar heart rate monitor and Sphygomanometer √√ √
Self-Reported Function
Physical activity and exercise participation
% taking moderate and vigorous exercise 3 
times per week
International Physical Activity 
Questionnaire(IPAQ) [40].
√√ √
Health Related Quality of Life COOP/WONCA Functional health status charts 
[43]








Smoking – % smoking
Diet
Self Reported Status
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Outcome Measures
The outcomes of interest can be categorised under the fol-
lowing headings:
1. Change in cardiovascular disease risk
2. Change in health behaviour
3. Change in body objective physical status and physical
fitness indices
4. Change in self-reported functioning
The variables and measurement instruments which will
be employed are summarised in table 2. Measures will be
taken at baseline, at completion of the 10 week interven-
tion programme and at 1 year post intervention. Both the
short-term and long-term outcomes are illustrated.
(a) Treatment group
The Intensive Rehabilitation Programme will consist of a
10 week schedule. Baseline measures will be taken during
week 1, and an individually tailored exercise training pro-
gramme prescribed. Training intensity will conform to the
recommendations of the American Heart Association,
American Stroke Association and American College of
Sports Medicine guidelines for aerobic training in patients
with cardiac risk [22]. During the subsequent 8 weeks the
participants will attend twice weekly for one hour individ-
ually tailored fitness training (warm up, cycle ergometry
(Motomed or Tunturi cycle ergometer) using either the
upper or lower limbs, treadmill training, step work at up
to 60% of their maximal heart rate). They will also attend
the two hour risk reduction lecture and receive smoking
cessation, physical activity and diet counselling appropri-
ate to their needs, in accordance with the World Health
Organisation (WHO) guidelines [44]. Reassessment will
take place on the 10th week.
The exercise sessions will be supervised by a physiothera-
pist (OL). Exercise will be stopped if any of the following
adverse events occur: chest pain, dizziness, malaise, heart
rate in excess of 60% maximal heart rate, oxygen satura-
tion levels lower than 90% and request from participant
to stop in accordance with American Heart Association
guidelines for exercise testing [45]. Staff with cardiac
resuscitation and defibrillation training will be on site
during the exercise sessions and the cardiac arrest proce-
dures of the community hospital will apply, immediate
first aid and emergency services will be called should an
adverse cardiac event occur.
(b) Control Group
Subjects allocated to the control group will have baseline
assessment on week 1 and re-assessment on week 10.
They will attend the two hour didactic lecture on risk
reduction post stroke and stress management.
Data Collection and Statistical Analysis
Data collected will be recorded on a pro-forma collection
sheet and will be entered onto Microsoft Excel and the Sta-
tistical Package for the Social Sciences (SPSS v12.0). Anal-
ysis will be conducted on an intention to treat basis and
withdrawals from the programme will be followed up to
ensure complete data. A last measurement carried forward
method will be used to predict outcome where drop-outs
occur [46]. Baseline data will be reported using descriptive
and frequency statistics.
Change scores occurring over the 10 week trial period and
between baseline and 1 year will be compared between
intervention and control groups using:
▪ Independent t tests and one-way ANOVA where data are
interval or ratio level and conform to the assumptions of
normality i.e. Cardiac Risk Score, VO2, Maximal work
output (Watts), Peak Pressure Rate Product, Lipid profile
(Total Cholesterol, HDL, LDL, Triglyceride).
▪ Non-parametric tests (Mann Whitney and Kruskall Wal-
lis tests) will be used for ordinal level data (Hospital Anx-
iety and Depression Scale, Stroke Specific QoL) or where
a normal data distribution is not found.
▪ Categorical variables will be analysed using Chi square
tests (% smoking, % taking moderate and vigorous exer-
cise 3 times per week, % meeting 2 fruit/3 veg daily guide-
lines).
Ethical Considerations and Confidentiality
The study conforms to the guidelines of University Col-
lege Dublin Human Research Ethics Sub-committee (Ref
HREC-19-06-Blake). Ethical approval has also been
obtained from Saint James's Hospital SHJ/Adelaide,
Meath and National Children's Hospitals AMNCH
Research Ethics Committee (Ref REC: 2008/07/03)
All participants will be volunteers. Informed consent will
be sought from participants following the distribution of
an information leaflet and screening for exclusion criteria.
Participants will be free to withdraw without prejudice at
any time. Since the type of cardiac rehabilitation pro-
gramme under investigation is not currently available to
the Stroke/TIA population, there are no ethical considera-
tions relating to the allocation of participants to a control
group.
All information collected relating to participants will be
confidential and will be stored securely in a locked cabi-
net in University College Dublin. Participants will beBMC Neurology 2009, 9:9 http://www.biomedcentral.com/1471-2377/9/9
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given a code on entering the study. This will be the only
link between the participants name and data.
Discussion
This study builds on a promising pilot study resulting in a
reduced cardiac risk score and improved fitness profiles
and sense of well being. It is hoped that success of the Car-
diac Rehabilitation Paradigm adapted to the Stroke and
TIA population will help inform the care-pathway and
enhance health and social gain in this population. While
a reduction of morbidity and mortality rates are not stated
outcomes of this study, the incidence of new cardiovascu-
lar disease events (Cardiac death, non fatal MI, CABG,
PTCA, angina, stroke death, non-fatal stroke and TIA) will
be monitored in the intervention and control groups over
the 1 year follow up period. It is acknowledged that the
study is not powered to determine differences in morbid-
ity and mortality, but it is planned to build on this study
to determine longer term benefit.
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